1. Home
  2. GMED vs PODD Comparison

GMED vs PODD Comparison

Compare GMED & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

HOLD

Current Price

$75.66

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$159.11

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMED
PODD
Founded
2003
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
10.3B
IPO Year
2012
2007

Fundamental Metrics

Financial Performance
Metric
GMED
PODD
Price
$75.66
$159.11
Analyst Decision
Buy
Buy
Analyst Count
14
21
Target Price
$100.42
$341.48
AVG Volume (30 Days)
1.9M
1.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
422.67
N/A
EPS
0.90
1.30
Revenue
$2,938,931,000.00
$2,708,100,000.00
Revenue This Year
$11.13
$24.55
Revenue Next Year
$6.28
$19.18
P/E Ratio
$84.43
$125.94
Revenue Growth
16.65
30.73
52 Week Low
$51.79
$138.79
52 Week High
$101.40
$354.88

Technical Indicators

Market Signals
Indicator
GMED
PODD
Relative Strength Index (RSI) 43.60 50.12
Support Level $75.24 $141.67
Resistance Level $86.21 $164.59
Average True Range (ATR) 3.03 6.21
MACD -0.22 0.34
Stochastic Oscillator 17.18 35.50

Price Performance

Historical Comparison
GMED
PODD

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: